gammaCore™ Financial Assistance Guide
CHAMP has created this financial assistance guide for anyone who has been prescribed gammaCore™ by their healthcare provider. gammaCore™ is a non-drug treatment that provides vagus nerve stimulation to help block the pain signals that cause migraine and cluster attacks. It has been approved for adults living with migraine disease and cluster disease. If you or someone you know requires help with paying for treatment, please review the details provided below to see if you qualify for the manufacturer’s (electoCore™) financial assistance program and how best to access gammaCore™.
Many insurers have not yet decided if or how they will cover the costs of gammaCore™. If you are prescribed gammaCore™, electroCore™ is offering financial assistance programs to help cover the costs. Each program is different and various programs exist to support patients with private, government-funded insurance, as well as the uninsured.
Please note: This guide has not been produced or approved by the manufacturer of gammaCore™. CHAMP does not endorse the use of any treatment over another, nor promote the use of this treatment for everyone living with migraine or cluster disease. Please consult your healthcare providers to determine if vagus nerve stimulation is right for you.
I Have Been Prescribed gammaCore™. What Financial Assistance Programs Exits To Help Me?
Private Insurance
I Have a Private/Commercial Insurance Plan
This category includes insurance plans provided through an employer, purchased with subsidy support from the Affordable Care Act (Obamacare) or purchased privately.
Highlights of gammaCore™ Co-Pay Assist Savings Offer
Depending on your insurance coverage of gammaCore™, eligible insured patients and those paying cash will receive up to $300 of assistance for your out-of-pocket costs on your first month of treatment and up to $250 for 11 subsequent months of treatment. You may not participate in this offer while enrolled in Partners for Coverage (see below) or while receiving any additional co-pay assistance.
Steps to Receive Co-Pay Assist Savings Offer
Medicare/Medicaid
I Have Medicare, Medicaid or other Government Insurance Plan
At this time electroCore™ does not have a financial assistance program for those with Medicare, Medicaid or other government insurance plans.
Uninsured
I am Uninsured
For those without commercial insurance, electroCore™ has a Co-pay Assist program. Through Co-pay Assist, qualified patients may be eligible to receive co-pay assistance of up to $300 on the first month and up to $250 for each following month for a maximum of 12 months. To learn more go to: gammaCore.com/patient-support/.
Need More Help
Where Do I Turn If I need More Help?
The Patient Advocate Foundation (a CHAMP member organization) PAf Patient Advocate can be a helpful resource for patients and caregivers who are experiencing access challenges. PAF provides a suite of expert tips to help navigate insurance denials, appeals and common barriers at: patientadvocate.org/migrainematters.
PAF also offers one-on-one case management assistance through its dedicated Migraine Careline for people living with migraine who experience access challenges. The Migraine Careline provides assistance with navigating eligibility and enrollment in disability benefits and overcoming insurance coverage and financial burdens that impact patient access to care.
All services are completely free and provided through phone and/or email communication. Visit migraine.pafcareline.org or call 866-688-3625 to speak with a case manager today.
gammaCore™ Basics
| Item | Description |
|---|---|
| Brand Name | gammaCore™, gammaCore Shapphire™ |
| Device Manufacturer | electroCore™ |
| Administration | For acute treatment of migraine disease: self-administer 2, two-minute gammaCore™ (nVNS) stimulations applied at the onset of pain or symptoms. Stimulations may be placed on either side of the neck at the correct treatment location and positioning on the neck to activate the vagus nerve. This treatment can be repeated at 20-minutes and 2-hours from start of first treatment if symptoms remain. For adjunctive use for the preventive treatment of cluster disease: two self-administered treatments (morning and night) consisting of 3, consecutive two-minute stimulations should be applied daily. For acute treatment of episodic cluster disease: self-administered, 3, two-minute stimulations applied consecutively at the onset of cluster disease pain or symptoms followed by an additional 3, two-minute stimulations if pain persists. Your doctor can help you with the proper administration and positioning. Additional details on administration can be found on the full prescribing information at https://www.gammacore.com/wp-content/themes/gammacore-p2/pdf/gammacore_IFU.pdf or by speaking with a gammaCARE Specialist at 1-844-632-9264, Monday-Friday, 8 AM – 8 PM ET. |
| Indication | Adults living with either chronic migraine disease (15 or more headache days per month) or episodic migraine disease (fewer than 15 headache days per month) for acute treatment. Adults living with cluster headache for preventive treatment and adults living with episodic cluster headache disease for acute treatment. |
| Full Prescribing Information | https://www.gammacore.com/wp-content/themes/gammacore-p2/pdf/gammacore_IFU.pdf |
| Website | gammacore.com |
| Helpline | The gammaCARE team can be reached at 1-844-632-9264, Monday-Friday, 8 am-8 pm ET or text JOIN to 75686 to receive information about migraine disease, gammaCore™, insurance support, refill reminders and more. |
| Administration Training Available | Yes, training on how to use gammaCore™ from a trained Care Specialist is available at 1-844-632-9264, Monday – Friday, 8 am-8 pm ET |
| Home Delivery Available | Yes, your prescription is sent to a specialty pharmacy partner that schedules direct delivery to your home. |